share_log

Benchmark Initiates Coverage On Nutex Health With Buy Rating, Announces Price Target of $3

Benzinga Real-time News ·  Dec 23, 2022 08:34

Benchmark analyst Bill Sutherland initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating and announces Price Target of $3.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment